Welcome to the 2nd Peptide Formulation & Delivery Innovation Summit
Peptide bioavailability has been significantly enhanced in recent years, evidenced by Pfizer developing an optimized formulation for its oral GLP-1 drug danuglipron, AbbVie buying out Nimble Therapeutics for its oral peptide assets and J&J advancing development of its IL-23 receptor antagonist peptide to address the high unmet need for a durable oral option. Additionally, innovative excipient and delivery approaches are making oral administration of peptides a clinical reality, but bottlenecks remain.
Returning to Boston as your premier industry-dedicated forum, the 2nd Peptide Formulation & Delivery Innovation Summit addresses how to overcome unique formulation challenges and accelerate innovative delivery technology applications to progress peptide-based therapeutic pipelines towards patients and commercialization.
As peptide-based therapeutics continue to be touted as the Goldilocks drug modality and are set to seriously disrupt the drug development landscape, join this forum to stay ahead of the curve:




Learn about state-of-the-art peptide formulation technologies such as permeation enhancers, nanoparticle encapsulation and structural modification abilities
Overcome technical and scientific challenges in optimizing peptide stability and bioavailability for oral, injectable, inhaled and intra-dermal formulations
Build partnerships with excipient and ingredient providers, device testing services, pre-clinical models and CDMOs that are well-versed in optimizing novel or reformulated peptide drugs, and scaling up manufacturing without compromising drug safety or efficacy
Be part of the industry-dedicated peptide formulation and delivery community that is spearheading innovative peptide formulation and delivery technologies to enhance peptide drug constitution without impacting efficacy, ensure patient adherence and accelerate peptide drug product towards approval.
Your Expert Speaker Faculty Includes:





Ruzica Kolakovic
Senior Principal Scientist, Drug Product Development Scientific Integrator
Johnson & Johnson

Previous Attendees Include:

Proud to partner with:
